July 13, 2023

27th Annual Symphony at Salk to feature GRAMMY® Award-winner Jennifer Hudson

Salk Nachrichten


27th Annual Symphony at Salk to feature GRAMMY® Award-winner Jennifer Hudson

LA JOLLA—On Saturday, August 19, the Salk Institute will celebrate 27 years of Symphony at Salk, its premier annual fundraiser and concert under the stars, with the breathtaking sounds of the San Diego Symphony and guest performer Jennifer Hudson, a two-time GRAMMY Award-winning recording artist, Academy Award-winning actress, and Tony and Emmy Award-winning producer.

Jennifer Hudson
Jennifer Hudson
Klicken Sie hier für ein hochauflösendes Bild.
Credit: ABDM

The unique experience includes a champagne reception and gourmet dinner along with immersive entertainment set in the ambiance of the Louis Kahn-designed architectural landmark overlooking the Pacific Ocean.

“Symphony at Salk blends science and art to inspire creativity and enrich our understanding of the world,” Salk President Gerald Joyce says. “I am looking forward to the exciting entertainment and the opportunity to showcase our world-class Institute, and I hope many new supporters and community members will join us for an unforgettable evening.”

Event proceeds help drive the Salk Institute’s wide-ranging scientific inquiries that have yielded more than 60 years of life-changing discoveries. The Institute, an independent nonprofit, seeks to understand the foundations of biology and address pressing global challenges such as cancer, aging, and climate change.

Sponsorships and individual tickets are available now at www.salk.edu/symphony. For more information, please call 858-597-0657.

Für weitere Informationen

Büro für Kommunikation
Telefon: (858) 453-4100
press@salk.edu

Das Salk-Institut für biologische Studien:

Das Salk Institute ist ein unabhängiges, gemeinnütziges Forschungsinstitut, das 1960 von Jonas Salk, dem Entwickler des ersten sicheren und wirksamen Polio-Impfstoffs, gegründet wurde. Die Aufgabe des Instituts besteht darin, grundlegende, kooperative und risikofreudige Forschung voranzutreiben, die sich mit den dringendsten Herausforderungen der Gesellschaft befasst, darunter Krebs, Alzheimer und die Gefährdung der Landwirtschaft. Diese Grundlagenforschung bildet die Basis für alle translationalen Bemühungen und führt zu Erkenntnissen, die neue Medikamente und Innovationen weltweit ermöglichen.